Literature DB >> 20111820

[Epidemiology of the meningococcal disease in Catalonia before and after vaccination against serogroup C].

Ana I Martínez1, Angela Domínguez, Manuel Oviedo, Sofía Minguell, Josep M Jansà, Gemma Codina, Julio A Vázquez.   

Abstract

BACKGROUNDS: Meningococcal disease remains a serious public health problem worldwide. In Catalonia, after implementing the vaccination program, there has been a significant decrease in cases caused by meningococcus C.
METHODS: Reported cases of meningococcal disease between 1997 and 2008 were analyzed to determine the evolution after the introduction of a conjugated vaccine in Catalonia.
RESULTS: In < 6 years, the incidence rate of serogroup C fell from 7.6 to 0.6 per 100,000 persons/year in the periods before (1997-2000) and after (2001-2007) the introduction of the conjugate vaccine. In serogroup B, the reduction was from 15.4 to 11.1. In < 20 years case-fatality-rate increased only in serogroup B (3% and 7.4%). Serosubtype P1.15was the most frequent in serogroup B (31%), mainly associated with serotype 4 (80%), and in serogroup C subtype P1.5 (36%), with serotype 2a (86%). During 2008, 5 apparently unrelated cases of B:2a:P1.5 were identified in the same geographic area, with a case-fatality-rate of 80%.
CONCLUSIONS: Exhaustive surveillance of circulating meningococcal strains is essential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20111820     DOI: 10.1590/s1135-57272009000500013

Source DB:  PubMed          Journal:  Rev Esp Salud Publica        ISSN: 1135-5727


  3 in total

1.  Epidemiology of vaccine-preventable invasive diseases in Catalonia in the era of conjugate vaccines.

Authors:  Pilar Ciruela; Ana Martínez; Conchita Izquierdo; Sergi Hernández; Sonia Broner; Carmen Muñoz-Almagro; Àngela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

2.  Meningococcal disease serogroup C.

Authors:  Félix O Dickinson; Antonio E Pérez; Iván E Cuevas
Journal:  Risk Manag Healthc Policy       Date:  2012-03-08

3.  Invasive Meningococcal Disease: What We Should Know, Before It Comes Back.

Authors:  Carmen Cabellos; Ivan Pelegrín; Eva Benavent; Francesc Gudiol; Fe Tubau; Dolores Garcia-Somoza; Ricard Verdaguer; Javier Ariza; Pedro Fernandez Viladrich
Journal:  Open Forum Infect Dis       Date:  2019-02-07       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.